Maven Securities LTD Takes $3.03 Million Position in SPDR S&P Biotech ETF $XBI

Maven Securities LTD acquired a new stake in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the second quarter, Holdings Channel reports. The firm acquired 19,147 shares of the exchange traded fund’s stock, valued at approximately $3,028,000.

Several other large investors have also recently added to or reduced their stakes in the business. Compound Planning Inc. lifted its holdings in SPDR S&P Biotech ETF by 0.7% during the 1st quarter. Compound Planning Inc. now owns 10,889 shares of the exchange traded fund’s stock worth $1,391,000 after buying an additional 75 shares in the last quarter. PeakShares LLC grew its stake in shares of SPDR S&P Biotech ETF by 5.2% in the first quarter. PeakShares LLC now owns 1,684 shares of the exchange traded fund’s stock worth $215,000 after acquiring an additional 84 shares in the last quarter. Commerce Bank grew its stake in shares of SPDR S&P Biotech ETF by 2.8% in the fourth quarter. Commerce Bank now owns 3,260 shares of the exchange traded fund’s stock worth $397,000 after acquiring an additional 90 shares in the last quarter. Moors & Cabot Inc. increased its position in shares of SPDR S&P Biotech ETF by 3.8% during the third quarter. Moors & Cabot Inc. now owns 2,717 shares of the exchange traded fund’s stock worth $272,000 after acquiring an additional 100 shares during the period. Finally, Cornerstone Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 1.6% during the fourth quarter. Cornerstone Wealth Management LLC now owns 7,727 shares of the exchange traded fund’s stock worth $942,000 after acquiring an additional 123 shares during the period.

SPDR S&P Biotech ETF Trading Down 1.1%

Shares of NYSEARCA XBI opened at $161.93 on Wednesday. The stock has a market cap of $10.57 billion, a P/E ratio of 11.47 and a beta of 0.84. The business’s fifty day simple moving average is $158.37 and its 200-day simple moving average is $141.16. SPDR S&P Biotech ETF has a 12-month low of $92.64 and a 12-month high of $169.89.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.